In March 2021, the CBTDDC launched the Clinical Trials Working Group for CNS Drug Delivery. This group has identified the main challenges in preclinical to clinical translation of paediatric CNS drug delivery devices as:
- a lack of specific funding for prototype development and/or scale-up for clinical trials;
- difficulties in navigating the regulatory landscape;
- lack of accurate preclinical models; and
- increased need for multicentric working.
We are now hosting a ‘Clinical Trial Readiness for CNS Drug Delivery’ workshop to tackle these challenges, with the ultimate aim of creating a ‘Roadmap’ document for preclinical to clinical translation that we can share widely with the neuro-oncology community.
CBTDDC, through a grant from Children with Cancer UK, will subsidize most of the costs associated with delegate attendance at this workshop, including lunch on both days, high-tech audiovisual support to ensure a successful hybrid (in-person and virtual) meeting, plus an evening meal and accommodation on the 8th November.
We will require all delegates to pay a basic registration fee of £50 per person.
We are seeking CPD accreditation for this event.
To cancel or amend your registration, email email@example.com
For cancellations made from 8th September 2021 onwards, no refunds will be available.